ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)

CUSIP: 04280A100

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / Common Stock
Shares outstanding
135,488,140
Total 13F shares
58,944,394
Share change
+367,614
Total reported value
$1,081,619,759
Put/Call ratio
119%
Price per share
$18.35
Number of holders
172
Value change
+$8,000,225
Number of buys
85
Number of sells
78

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q1 2019

As of 31 Mar 2019, ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 58,944,394 shares. The largest 10 holders included OppenheimerFunds, Inc., BlackRock Inc., VANGUARD GROUP INC, FIRST MANHATTAN CO, STATE STREET CORP, Vivo Capital, LLC, FARALLON CAPITAL MANAGEMENT LLC, FMR LLC, Fiera Capital Corp, and RTW INVESTMENTS, LP. This page lists 172 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 holders
156
Q1 2019 holders
172
Holder diff
16
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 Value $ Q1 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.